| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.039 | 0.3 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | GW-405833 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.3 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |
| mRNA | BRD-K84807411 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.079 | 0.3 |
| mRNA | pac-1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | 0.037 | 0.3 |